MAPK8 and acute myeloid leukemia: Several anti-cancer compounds such as trifolin acetate [4], fucoidan [5] and 3,6-dihydroxyflavone [6] activated ERK, JNK and/or p38, in human acute myeloid leukemia HL60 cells.